Bronchial reactivity for histamine and serum angiotensin converting enzyme (sACE) activity in sarcoidosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 669s Year: 2004
Clinical significance of angiotensin converting enzyme (ACE) activity in sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 384s Year: 2001
Serum angiotensin converting enzyme (ACE) as additional clinical markers of activity of pulmonary and extra-pulmonary locations of sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011
Activity and phenotypes of angiotensin-converting enzyme (ACE) in sarcoidosis with various organ involvement Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020
Impact of statins, angiotensin-converting enzyme inhibitors (ACEI), and angiotensin receptor blockers (ARBS) on reducing COPD morbidity Source: Annual Congress 2009 - Treatment of airways disease Year: 2009
Circulating d-Dimer lysozyme and angiotensin-converting enzyme in active sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 196s Year: 2001
Impact of statins, angiotensin-converting enzyme inhibitors(ACEI), and angiotensin receptor blockers (ARBs) on reducing COPD morbidity Source: Annual Congress 2010 - COPD: management Year: 2010
Angiotensin II receptor blockers, ACE inhibitors, lung function and percent emphysema; the MESA lung study Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012
Correlation between angiotensin-converting enzyme (ACE) gene polymorphism and exercise performance in COPD patients Source: Annual Congress 2010 - Exercise in COPD Year: 2010
Anti-asthmatic effects of losartan, a blocker of angiotensin II type 1 receptor, in a rat model of allergic asthma Source: Annual Congress 2009 - Preclinical models in drug development Year: 2009
Angiotensin-converting enzyme genotype and C-reactive protein in patients with COPD Source: Eur Respir J 2007; 29: 816-817 Year: 2007
Angiotensin-converting enzyme 2 expression is not induced by the renin–angiotensin system in the lung Source: ERJ Open Res, 6 (4) 00402-2020; 10.1183/23120541.00402-2020 Year: 2020
Effectiveness and safety of the antihypertensive treatment with ACE inhibitors (ACEi) and their combination with calcium antagonists (CA) of the patients with bronchial asthma (BA) and arterial hypertension (AH) Source: Annual Congress 2008 - Asthma control or asthma severity Year: 2008
The in vivo activity of AWD 12-353, a potent phosphodiesterase 4 (PDE) inhibitor for the treatment of allergic asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003
Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population Source: Eur Respir J 2006; 27: 1217-1222 Year: 2006
Identification of wheatsubtilisin/chymotrypsin inhibitor (WSCI) as an important allergen for Baker‘s asthma Source: Eur Respir J 2006; 28: Suppl. 50, 677s Year: 2006
Effect of angiotensin converting enzyme (ACE) gene polymorphism on diaphragmatic endurance in neonates Source: Annual Congress 2008 - Neonatal intensive care: ventilation and beyond Year: 2008
Value of serum angiotensin converting enzyme (SACE) level in the assessment of lung parenchyma impairment in newly diagnosed sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 45s Year: 2003
Etiology specific reductions in pulmonary endothelial angiotensin converting enzyme activity in patients with PAH Source: Eur Respir J 2006; 28: Suppl. 50, 658s Year: 2006
Cough among hypertensive patients treated with angiotensin convertase inhibitors. Reduction of its frequency by substitution of angiotensin convertase inhibitor with angiotensin receptor blocker. Results of non-interventional, observational postmarketing study Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011